Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients
EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients
EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients
Submitted by
admin
on October 26, 2016 - 9:30am
Source:
Forbes
News Tags:
EpiPens
Auvi-Q
Kaleo
Mylan Labs
Headline:
EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients
Do Not Allow Advertisers to Use My Personal information
